Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Standard

Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. / Astrup, Arne; Carraro, Romina; Finer, N; Harper, A; Kunesova, M; Lean, M E J; Niskanen, L; Rasmussen, M F; Rissanen, A; Rössner, S; Savolainen, M J; Van Gaal, L.

I: International Journal of Obesity, Bind 37, Nr. 2, 2013, s. 322.

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Harvard

Astrup, A, Carraro, R, Finer, N, Harper, A, Kunesova, M, Lean, MEJ, Niskanen, L, Rasmussen, MF, Rissanen, A, Rössner, S, Savolainen, MJ & Van Gaal, L 2013, 'Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide', International Journal of Obesity, bind 37, nr. 2, s. 322. https://doi.org/10.1038/ijo.2012.192

APA

Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E. J., ... Van Gaal, L. (2013). Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. International Journal of Obesity, 37(2), 322. https://doi.org/10.1038/ijo.2012.192

Vancouver

Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean MEJ o.a. Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. International Journal of Obesity. 2013;37(2):322. https://doi.org/10.1038/ijo.2012.192

Author

Astrup, Arne ; Carraro, Romina ; Finer, N ; Harper, A ; Kunesova, M ; Lean, M E J ; Niskanen, L ; Rasmussen, M F ; Rissanen, A ; Rössner, S ; Savolainen, M J ; Van Gaal, L. / Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. I: International Journal of Obesity. 2013 ; Bind 37, Nr. 2. s. 322.

Bibtex

@article{ecfbb1c675ca4a1993387dc354a97855,
title = "Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide",
author = "Arne Astrup and Romina Carraro and N Finer and A Harper and M Kunesova and Lean, {M E J} and L Niskanen and Rasmussen, {M F} and A Rissanen and S R{\"o}ssner and Savolainen, {M J} and {Van Gaal}, L",
note = "CURIS 2013 NEXS 057",
year = "2013",
doi = "10.1038/ijo.2012.192",
language = "English",
volume = "37",
pages = "322",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "nature publishing group",
number = "2",

}

RIS

TY - JOUR

T1 - Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

AU - Astrup, Arne

AU - Carraro, Romina

AU - Finer, N

AU - Harper, A

AU - Kunesova, M

AU - Lean, M E J

AU - Niskanen, L

AU - Rasmussen, M F

AU - Rissanen, A

AU - Rössner, S

AU - Savolainen, M J

AU - Van Gaal, L

N1 - CURIS 2013 NEXS 057

PY - 2013

Y1 - 2013

U2 - 10.1038/ijo.2012.192

DO - 10.1038/ijo.2012.192

M3 - Comment/debate

C2 - 23399800

VL - 37

SP - 322

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - 2

ER -

ID: 44853834